These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.
“You and I don’t get to choose the cancer we get,” says Dr. Joshua Ofman of Grail, Inc. But with this breakthrough lab test, doctors can choose to screen for over 50 types of cancers—about 10 times as many as can be screened for with current recommended tests. Galleri’s machine learning technology looks for circulating tumor DNA from a blood draw and claims a low false positive rate and high positive predictive value—in other words, it’s accurate. In the recent Pathfinder study, about 50% of the detected cancers were early stage. “Localized cancers in Stage 1 and 2 are often curable,” Ofman notes.
Request Now: Grail Galleri Cancer Test
More Must-Reads from TIME
- Why Trump’s Message Worked on Latino Men
- What Trump’s Win Could Mean for Housing
- The 100 Must-Read Books of 2024
- Sleep Doctors Share the 1 Tip That’s Changed Their Lives
- Column: Let’s Bring Back Romance
- What It’s Like to Have Long COVID As a Kid
- FX’s Say Nothing Is the Must-Watch Political Thriller of 2024
- Merle Bombardieri Is Helping People Make the Baby Decision
